BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7985953)

  • 1. Long-term plasma exchange. Analysis of indications, outcome and side effects.
    Karmochkine M; Bussel A; Léon A; Jarrousse B; Baudelot J; Guillevin L
    Ann Med Interne (Paris); 1994; 145(5):373-5. PubMed ID: 7985953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cryoglobulinemia with encephalopathy: successful treatment by plasma exchange.
    Reik L; Korn JH
    Ann Neurol; 1981 Nov; 10(5):488-90. PubMed ID: 7305302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma exchange in dermatomyositis and polymyositis. Retrospective study of 38 cases of plasma exchange].
    Herson S; Lok C; Roujeau JC; Coutellier A; Etienne SD; Revuz J; Schooneman F; Gérard A; Godeau P
    Ann Med Interne (Paris); 1989; 140(6):453-5. PubMed ID: 2696399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The treatment of peripheral neuropathies in a case of IgA myeloma and one of mixed cryoglobulinaemia. Repeated plasmapheresis (author's transl)].
    Betourné C; Buge A; Dechy H; Dorra M; Dournon E; Rancurel G
    Nouv Presse Med; 1980 Apr; 9(19):1369-71. PubMed ID: 6247702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of immune-mediated, dysimmune neuropathies.
    Finsterer J
    Acta Neurol Scand; 2005 Aug; 112(2):115-25. PubMed ID: 16008538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of peripheral neuropathies associated with IgM anti-myelin monoclonal gammopathy].
    Mariette X; Oksenhendler E
    Rev Neurol (Paris); 1996 May; 152(5):413-6. PubMed ID: 8881442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma exchange in the treatment of cryoglobulinaemia.
    Derksen RH; Hené RJ; Gmelig Meyling FH; Kater L
    Neth J Med; 1983; 26(10):294-300. PubMed ID: 6656974
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapeutic plasmapheresis in essential monoclonal cryoglobulinemia].
    Golenkov AK; Zlatkina AR; Ivanov MI; Lipats AA; Podushko TA
    Sov Med; 1983; (1):96-7. PubMed ID: 6836402
    [No Abstract]   [Full Text] [Related]  

  • 9. [Use of plasmapheresis in patients with AIDS and peripheral polyneuropathy].
    Lapiński TW; Prokopowicz D
    Pol Merkur Lekarski; 1999 Nov; 7(41):215-7. PubMed ID: 10680453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmapheresis: a therapeutic option for treatment of selected patients.
    Ginder PA; Middendorf DF; Abdou NI
    J Kans Med Soc; 1982 Mar; 83(3):140-2. PubMed ID: 7077118
    [No Abstract]   [Full Text] [Related]  

  • 11. [Plasma exchange in cryoglobulinemia with cryoglobulin-depleted own plasma].
    Omori K; Baba M; Maeda Y; Kawamura M; Hirano H
    Rinsho Ketsueki; 1983 Jul; 24(7):924-8. PubMed ID: 6632232
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasma exchange in the management of hyperviscosity syndromes.
    Isbister JP
    Bibl Haematol; 1981; (47):228-41. PubMed ID: 7337664
    [No Abstract]   [Full Text] [Related]  

  • 13. [The effect of plasmapheresis and other immunomodulating therapies on the course of severe Guillain-Barré syndrome].
    Hidasi E; Soltész P
    Orv Hetil; 2001 Feb; 142(7):335-9. PubMed ID: 11243015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term regular plasmapheresis as a maintenance treatment for chronic inflammatory demyelinating polyneuropathy.
    Isose S; Mori M; Misawa S; Shibuya K; Kuwabara S
    J Peripher Nerv Syst; 2010 Jun; 15(2):147-9. PubMed ID: 20626778
    [No Abstract]   [Full Text] [Related]  

  • 15. [Favorable results of plasmapheresis in severe myasthenia gravis].
    Blom RJ; Kuks JB; Westerterp-Maas A; Oosterhuis HJ
    Ned Tijdschr Geneeskd; 1997 Feb; 141(8):381-4. PubMed ID: 9157298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Plasma exchange therapy (plasmapheresis/plasmafiltration). II. Indications and complications].
    Quietzsch D; Liebert A; Zimmermann S
    Z Gesamte Inn Med; 1984 Oct; 39(20):493-500. PubMed ID: 6549091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acute phase reactant, fibrinogen, as a guide to plasma exchange therapy for acute Guillain-Barré syndrome.
    Sanjay R; Flanagan J; Sodano D; Gorson KC; Ropper AH; Weinstein R
    J Clin Apher; 2006 Jul; 21(2):105-10. PubMed ID: 16342192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute renal failure in essential mixed cryoglobulinemia: precipitation and reversal by plasma exchange.
    Evans TW; Nicholls AJ; Shortland JR; Ward AM; Brown CB
    Clin Nephrol; 1984 May; 21(5):287-93. PubMed ID: 6733996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune mediated neuropathies--an update on therapeutic strategies.
    Czaplinski A; Steck AJ
    J Neurol; 2004 Feb; 251(2):127-37. PubMed ID: 14991345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Use of plasma exchange in treating kidney failure from paraproteinemic diseases].
    Camerone G; Banfi L; Ferrari A; Garelli S; Valbonesi M
    Riv Emoter Immunoematol; 1980; 27(3-4):168-74. PubMed ID: 7339846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.